CRISPR Therapeutics AG logo
CRISPR Therapeutics AG CRSP
$ 40.62 0.57%

Quarterly report 2024-Q3
added 11-05-2024

report update icon

CRISPR Therapeutics AG EBITDA per Share 2011-2024 | CRSP

Annual EBITDA per Share CRISPR Therapeutics AG

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-2.56 -8.35 5.15 -5.24 0.946 -3.24 -1.54 -5.48 - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
5.15 -8.35 -2.54

Quarterly EBITDA per Share CRISPR Therapeutics AG

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
-1.24 -1.72 -1.66 - -1.61 -1.14 -0.76 - -2.27 -2.27 -2.2 - -1.54 10.1 -1.49 -1.51 -1.22 -1.24 -1.17 0.19 2.6 -1 -0.91 -0.88 -0.99 -0.76 -0.57 0.02 -0.53 -0.5 -0.5 -0.77 -2.66 -2.99 -2.09 -2.2 -1.11 -0.8 -1.05 - - - - - - - - - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
10.1 -2.99 -0.844